(Q35018381)

5 August 2017

Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma (English)

1 reference

5 August 2017

Bin T Teh

7

0 references

author name string

Nicholas J Hellenthal

1

1 reference

5 August 2017

Willie Underwood

2

1 reference

5 August 2017

Remedios Penetrante

3

1 reference

5 August 2017

Alan Litwin

4

1 reference

5 August 2017

Shaozeng Zhang

5

1 reference

5 August 2017

Gregory E Wilding

6

1 reference

5 August 2017

Hyung L Kim

8

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

5 August 2017

1 reference

5 August 2017

184

1 reference

5 August 2017

859-864

1 reference

5 August 2017

3

1 reference

Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

8 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Sunitinib in patients with metastatic renal cell carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokines

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Reporting results of cancer treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Estimation and prediction of renal function in patients with renal tumor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Sunitinib for treatment of advanced renal cell cancer: primary tumor response

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105599

Adjuvant therapy for renal cell carcinoma

25 October 2018

1 reference

12 December 2020

Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy

1 reference

12 December 2020

Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness

1 reference

12 December 2020

Rising incidence of small renal masses: a need to reassess treatment effect

1 reference

12 December 2020

10.1016/J.JURO.2010.05.041

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference